- MRSN Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Mersana Therapeutics (MRSN) 8-K1 Feb 23Company plans to report interim data for the combination of UpRi with carboplatin in the second half of 2023Financial data
Company Profile